Enlaza Therapeutics
SERVICES PROVIDED:
- Positioning Research
- Identity Design
- Campaign Development
- Website Design & Development
- Social Media Channel Design
- Original photography
Design Partner: Spirolab
Enlaza Therapeutics is a biopharmaceutical company developing first-in-class covalent protein therapeutics to transform the treatment of cancer.
22 Fillmore partnered with Enlaza to lead the design of the company’s brand identity as the biopharma was in the midst of raising its seed funding and expanding its leadership team.
The full scope of work included the design of the Enlaza logo, the build out the identity system, the creation of a corporate positioning campaign, and the design and development of a launch website.
In April of 2024, Enlaza announced the closing of $100 million in Series A financing led by the Life Sciences Group of J.P. Morgan Private Capital.
